Simplexia AB

Investor

Simplexia AB

Description

vaccine against herpes simplex virus type (HSV-2) infection

Simplexia AB

Address

Erik Dahlbergsgatan 11 A, Gothenburg 41129
Gothenburg, Sweden

Contact

info@simplexia.se

Description

vaccine against herpes simplex virus type (HSV-2) infection

Matchmaking

Connect with Simplexia AB

This entity is yours?

Update information

Position on the value chain

With the ultimate aim to create a European alliance for bioproduction in Europe, organisations have joined forces with COBIOE. Discover who are our associates.

Bio-resources and biobanking
  • Cells, tissues and humanized xeno-organs
  • Biosamples
  • Viral, phage or bacterial specimen
Identification of biotherapies
  • Target identification
  • Target validation
  • Screening
Drug design
  • Drug assessment
  • Drug engineering
  • In vitro preclinical studies
Clinical validation
  • Clinical trials
  • In vivo preclinical validation
  • Pre-industrial scale production
Production
  • Upstream processes
  • Downstream processes
  • Quality control
Market access
  • CE mark / market authorisation
  • Payment / Reimbursement
  • Care pathways

TRL